{"id":984,"date":"2026-07-06T09:47:39","date_gmt":"2026-07-06T09:47:39","guid":{"rendered":"https:\/\/www.fundavia.com\/uncategorized\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/"},"modified":"2026-07-06T09:47:39","modified_gmt":"2026-07-06T09:47:39","slug":"defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2","status":"publish","type":"post","link":"https:\/\/www.fundavia.com\/pt\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/","title":{"rendered":"The First Autism ETF Raises A Harder Question About Impact Investing"},"content":{"rendered":"<figure class=\"wp-block-image size-large\">\n<img loading=\"lazy\" decoding=\"async\" width=\"1080\" height=\"720\" src=\"https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085.jpg\" alt=\"\" class=\"wp-image-983\" srcset=\"https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085.jpg 1080w, https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085-300x200.jpg 300w, https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085-1024x683.jpg 1024w, https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085-768x512.jpg 768w, https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085-18x12.jpg 18w\" sizes=\"auto, (max-width: 1080px) 100vw, 1080px\" \/>\n<figcaption><em>Photo by Jakub \u017berdzicki (@jakubzerdzicki) on Unsplash<\/em><\/figcaption>\n<\/figure>\n\n\n<style>body.single-post .cm-featured-image { display: none !important; }<\/style>\n\n<meta charset=\"UTF-8\"><p class=\"isSelectedEnd\"><span>The <a href=\"https:\/\/www.fundavia.com\/pt\/investimento-em-indices-de-etfs\/etfs-tematicos\/os-10-etfs-tematicos-com-melhor-desempenho-em-2025\/\">ETF<\/a> industry has become very good at turning a theme into a ticker. Artificial intelligence, quantum computing, space, obesity drugs, defence technology, clean energy, covered calls, single-stock leverage: if investors can name a trend, there is often a fund trying to package it.<\/span><\/p><p class=\"isSelectedEnd\"><span>Defiance\u2019s new Autism Impact ETF, trading under the ticker ASD, is different in one important respect. It is not only trying to give investors exposure to a theme. It is trying to attach a social commitment to the economics of the fund itself.<\/span><\/p><p class=\"isSelectedEnd\"><span>Launched in June 2026, ASD is designed to track the VettaFi Autism Impact Index, which measures the performance of publicly traded global companies providing products, services or research that support autistic people and the broader neurodivergent community. Defiance says it will donate 100 percent of its net advisory profits from the fund for the first two years, and at least 50 percent thereafter, to autism care and research causes.<\/span><\/p><p class=\"isSelectedEnd\"><span>That makes the fund interesting. It also makes it worth examining carefully.<\/span><\/p><p class=\"isSelectedEnd\"><span>The important question is not whether autism deserves more funding, better services and more serious public attention. It does. The question is whether an ETF is a clean way to connect investor capital with social impact, and what investors are actually buying when they buy a product like ASD.<\/span><\/p><h2><span>A Cause Is Not The Same As An Investment Case<\/span><\/h2><p class=\"isSelectedEnd\"><span>Autism is not a niche social issue. The CDC describes autism spectrum disorder as a developmental disability that can involve social, communication and behavioural differences, and its latest surveillance data estimate that one in 31 eight-year-old children in the United States had been identified with autism spectrum disorder.<\/span><\/p><p class=\"isSelectedEnd\"><span>Behind that figure is a wide ecosystem of needs: diagnostics, therapies, communication tools, education, behavioural support, assistive technologies, care coordination, healthcare services, employment support and family resources. The breadth of that ecosystem partly explains why an autism-focused public-equity index is possible. There are listed companies with some link to healthcare, diagnostics, pharmaceuticals, education technology, behavioural services or assistive tools.<\/span><\/p><p class=\"isSelectedEnd\"><span>But that link should not be overstated. Buying shares in companies that touch the autism ecosystem is not the same as directly funding autism services. It is public-equity exposure first. The social element comes through Defiance\u2019s pledge to donate advisory profits, not through every dollar invested flowing into research or care.<\/span><\/p><p class=\"isSelectedEnd\"><span>That distinction matters because impact investing often suffers from blurred language. A fund can have socially relevant holdings. A fund can donate part of its economics. A fund can raise awareness. A fund can offer financial exposure to companies operating in an area of public need. These are related ideas, but they are not identical.<\/span><\/p><p class=\"isSelectedEnd\"><span>ASD sits at the intersection of all four. That is what makes it more interesting than a standard thematic ETF, but also more complicated.<\/span><\/p><h2><span>What The Fund Actually Is<\/span><\/h2><p class=\"isSelectedEnd\"><span>ASD is a new, rules-based equity ETF. According to Defiance, the fund is built around companies advancing autism therapeutics, diagnostics, education and care. The fund\u2019s page lists an inception date of 1 June 2026, an expense ratio of 0.79 percent, 40 holdings and net assets of about USD 1.32 million as of 26 June 2026.<\/span><\/p><p class=\"isSelectedEnd\"><span>Those numbers immediately tell investors two things.<\/span><\/p><p class=\"isSelectedEnd\"><span>First, this is an early-stage ETF. A fund with around USD 1 million in assets is still proving whether it can attract durable demand. That does not make it uninvestable, but it does mean liquidity, spreads and trading depth deserve attention. The fund\u2019s median 30-day spread was listed at 0.28 percent, which is not extreme for a new thematic ETF, but is still a real cost for investors entering or exiting positions.<\/span><\/p><p class=\"isSelectedEnd\"><span>Second, it is not a broad market product. A 0.79 percent expense ratio is materially higher than a low-cost S&amp;P 500 or global equity ETF. That fee may be defensible for a niche thematic product with an attached donation commitment, but investors should understand what they are paying for. The fund must justify itself either through differentiated exposure, values alignment, the donation mechanism or some combination of the three.<\/span><\/p><p class=\"isSelectedEnd\"><span>The investment objective, according to Morningstar\u2019s summary, is to track the total return performance, before fees and expenses, of the VettaFi Autism Impact Index. In plain English, this is not an actively managed social-impact portfolio where a manager selects companies case by case based on deep qualitative judgement. It is an index-tracking thematic ETF.<\/span><\/p><p class=\"isSelectedEnd\"><span>That makes the index methodology central.<\/span><\/p><h2><span>The Index Is The Real Product<\/span><\/h2><p class=\"isSelectedEnd\"><span>In thematic ETFs, the index often matters more than the headline. A fund\u2019s name tells investors the story. The index tells them what they actually own.<\/span><\/p><p class=\"isSelectedEnd\"><span>VettaFi says its Autism Impact Index is designed to measure publicly traded global companies that provide products, services and\/or research supporting the autism ecosystem, including autistic individuals and the broader neurodivergent community. It categorises the exposure as global, thematic, medical and healthcare-related.<\/span><\/p><p class=\"isSelectedEnd\"><span>That is a broad definition, and broad definitions can create both diversification and dilution.<\/span><\/p><p class=\"isSelectedEnd\"><span>Diversification is useful because the autism ecosystem is not one industry. A serious fund cannot rely only on one drug developer or one diagnostics company. It may need exposure across healthcare services, pharmaceutical research, genetic testing, education platforms, communication technologies, managed care and other adjacent areas.<\/span><\/p><p class=\"isSelectedEnd\"><span>Dilution is the risk. The broader the definition, the more likely the portfolio includes companies for which autism is only a small part of the business. A large healthcare company may have autism-relevant products or research but derive most of its revenue from unrelated areas. An education or technology company may support neurodivergent users but still be driven by broader commercial dynamics.<\/span><\/p><p class=\"isSelectedEnd\"><span>That does not make the index wrong. It does mean investors should avoid assuming the fund is a pure-play autism portfolio. Pure plays may barely exist in public markets at sufficient scale and liquidity. The practical ETF version of the theme is therefore likely to be a basket of companies with varying degrees of relevance.<\/span><\/p><p class=\"isSelectedEnd\"><span>This is the trade-off at the heart of many impact ETFs: the more investable the portfolio, the less pure the impact exposure may become.<\/span><\/p><h2><span>The Donation Pledge Is Unusual, But Needs Context<\/span><\/h2><p class=\"isSelectedEnd\"><span>The most distinctive feature of ASD is Defiance\u2019s donation commitment. The fund prospectus says the adviser has committed to donate 100 percent of its net advisory profits attributable to the fund during the first two years, and The Daily Upside reported that the minimum donation after that period will be 50 percent of advisory profits.<\/span><\/p><p class=\"isSelectedEnd\"><span>That is a stronger claim than vague impact branding. It ties the fund sponsor\u2019s economics to autism-related causes. But the phrase \u201cnet advisory profits\u201d matters.<\/span><\/p><p class=\"isSelectedEnd\"><span>A donation of advisory profits is not the same as a donation of assets under management, investment gains or total expense-ratio revenue. Net profit depends on the fund\u2019s assets, fee revenue, operating arrangements and costs. If the fund remains small, the absolute donation may also be small. If the fund grows significantly, the donation could become more meaningful.<\/span><\/p><p class=\"isSelectedEnd\"><span>This is not a criticism. It is the correct way to read the structure.<\/span><\/p><p class=\"isSelectedEnd\"><span>The pledge gives the product a philanthropic layer, but the scale of that layer depends on commercial success. Investors who buy ASD are not making a direct charitable contribution in the way they would by donating to an autism organisation. They are buying an ETF whose adviser has committed to donate part of its economics.<\/span><\/p><p class=\"isSelectedEnd\"><span>That difference should be explicit, because it protects the credibility of the product. Impact finance works better when it does not oversell itself.<\/span><\/p><h2><span>Thematic ETFs Have A Timing Problem<\/span><\/h2><p class=\"isSelectedEnd\"><span>Thematic ETFs are usually launched when a story is already visible. That can be good for marketing and difficult for returns.<\/span><\/p><p class=\"isSelectedEnd\"><span>A compelling theme does not automatically make a compelling entry point. Investors still need to ask whether the relevant companies are attractively valued, whether earnings growth supports the narrative, whether the index is concentrated, and whether the theme is already priced into the holdings.<\/span><\/p><p class=\"isSelectedEnd\"><span>ASD adds another complication: the autism ecosystem is socially important, but not necessarily a clean investment factor. Unlike semiconductors, uranium, defence or obesity drugs, autism-related exposure is not obviously tied to a single capital-expenditure cycle or revenue surge. The fund may hold companies connected to healthcare innovation, diagnostics, services, education or support technologies, but their share prices may be driven by many other factors: clinical trial outcomes, reimbursement policy, healthcare regulation, labour costs, insurance dynamics, broader equity-market sentiment and company-specific execution.<\/span><\/p><p class=\"isSelectedEnd\"><span>That means ASD should not be treated as a simple bet that \u201cautism awareness is rising\u201d. Awareness and investment performance are not the same thing.<\/span><\/p><p class=\"isSelectedEnd\"><span>The fund may appeal to investors who want a values-aligned satellite position and accept the risks of a narrow, new ETF. It is less obviously suitable as a core holding.<\/span><\/p><h2><span>The Social Case Is Stronger Than The Portfolio Purity<\/span><\/h2><p class=\"isSelectedEnd\"><span>There is a broader reason ASD is worth attention. It tests whether the ETF wrapper can do more than distribute exposure. It asks whether asset managers can use fund economics to support a cause without turning the cause into a slogan.<\/span><\/p><p class=\"isSelectedEnd\"><span>The answer will depend on execution.<\/span><\/p><p class=\"isSelectedEnd\"><span>Investors should look for clear reporting on donations: which organisations receive money, how much is donated, when donations are made, and whether those organisations focus on research, care, access, education, family support or autistic-led advocacy. Transparency will matter as much as the pledge itself.<\/span><\/p><p class=\"isSelectedEnd\"><span>They should also look at the holdings. Are the companies meaningfully connected to autism and neurodivergence, or only loosely adjacent? Does the index methodology explain the selection process clearly? Are large companies included because they have a serious role in the ecosystem, or because the fund needs liquidity? Are there controversies around care models, pricing, access or governance?<\/span><\/p><p class=\"isSelectedEnd\"><span>These questions are not hostile. They are necessary for a fund that wants to claim both thematic relevance and social purpose.<\/span><\/p><p class=\"isSelectedEnd\"><span>A cause-based ETF earns trust through specificity.<\/span><\/p><h2><span>What Investors Should Check Before Buying<\/span><\/h2><p class=\"isSelectedEnd\"><span>The first question is portfolio role. ASD is a niche thematic ETF with a short live track record. That usually belongs, if anywhere, in the satellite part of a portfolio, not as a substitute for broad equity exposure.<\/span><\/p><p class=\"isSelectedEnd\"><span>The second question is liquidity. New ETFs can trade with wider spreads and lower volume. Investors should consider using limit orders rather than market orders, especially in thinly traded funds.<\/span><\/p><p class=\"isSelectedEnd\"><span>The third question is cost. A 0.79 percent expense ratio is not unusual for a specialist thematic ETF, but it is high compared with broad passive funds. The investor needs to decide whether the thematic exposure and donation pledge justify the fee.<\/span><\/p><p class=\"isSelectedEnd\"><span>The fourth question is impact transparency. The donation mechanism is the feature that distinguishes ASD from ordinary thematic products. Investors should expect clear public reporting over time.<\/span><\/p><p class=\"isSelectedEnd\"><span>The fifth question is values fit. Autism is not only a medical or investment category. It is also a community with different views on language, support, research priorities and representation. Any product using autism as a theme needs to handle that with care.<\/span><\/p><p class=\"isSelectedEnd\"><span>That last point is not secondary. It is central to whether the fund is seen as serious or opportunistic.<\/span><\/p><h2><span>A Useful Innovation, Not A Moral Shortcut<\/span><\/h2><p class=\"isSelectedEnd\"><span>ASD is a thoughtful addition to the ETF market because it makes the economics of the sponsor part of the social proposition. That is more concrete than simply labelling a fund \u201cimpact\u201d because it owns companies in a fashionable sector.<\/span><\/p><p class=\"isSelectedEnd\"><span>But investors should resist the temptation to treat the fund as a moral shortcut. Buying ASD does not replace charitable giving. It does not guarantee direct improvement in autism services. It does not remove ordinary investment risk. It does not mean every holding is a pure autism company. It does not make the portfolio immune from valuation, liquidity or market-cycle problems.<\/span><\/p><p class=\"isSelectedEnd\"><span>What it does do is create a new model for cause-linked ETF design: targeted public-equity exposure, a defined social theme and a sponsor-level profit donation commitment.<\/span><\/p><p class=\"isSelectedEnd\"><span>That model may spread. There could be funds linked to rare diseases, disability access, mental health, ageing, education or other areas where public-market companies and philanthropic needs overlap. Some will be serious. Some will be marketing. The difference will be in the details: methodology, fees, donation reporting, governance and community engagement.<\/span><\/p><p class=\"isSelectedEnd\"><span>The launch of ASD is therefore less important as a one-off first and more important as a test. It asks whether ETF issuers can build products that are financially coherent, socially sensitive and transparent enough to withstand scrutiny.<\/span><\/p><p class=\"isSelectedEnd\"><span>For investors, the conclusion is measured. ASD may be a meaningful choice for someone who wants niche healthcare and support-services exposure with an autism-linked donation structure. But it should be assessed like any other ETF: what does it own, what does it cost, how does it trade, what risks does it carry, and what impact can it actually prove?<\/span><\/p><p><span>The cause deserves attention. The product deserves due diligence.<\/span><\/p>&nbsp;<meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\n    <title>Defiance Launches the First Autism-Impact ETF<\/title>","protected":false},"excerpt":{"rendered":"<p>Defiance has introduced the first autism-impact ETF, ASD, blending financial innovation with social responsibility. This initiative reflects a growing trend in equity-based ETFs to align with social causes.<\/p>","protected":false},"author":2,"featured_media":983,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"colormag_page_container_layout":"default_layout","colormag_page_sidebar_layout":"default_layout","footnotes":""},"categories":[8],"tags":[],"class_list":["post-984","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-equity-etfs"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes *<\/title>\n<meta name=\"description\" content=\"Defiance has introduced the first autism-impact ETF, ASD, blending financial innovation with social responsibility. This initiative reflects a growing trend in equity-based ETFs to align with social causes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fundavia.com\/pt\/investimento-em-indices-de-etfs\/etfs-de-acoes\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes *\" \/>\n<meta property=\"og:description\" content=\"Defiance has introduced the first autism-impact ETF, ASD, blending financial innovation with social responsibility. This initiative reflects a growing trend in equity-based ETFs to align with social causes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fundavia.com\/pt\/investimento-em-indices-de-etfs\/etfs-de-acoes\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Fundavia | Funds, ETFs &amp; Institutional Investing\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-06T09:47:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Warren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Warren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/\"},\"author\":{\"name\":\"Warren\",\"@id\":\"http:\\\/\\\/www.fundavia.com\\\/#\\\/schema\\\/person\\\/917222061ef2cf1c52b97293e690505b\"},\"headline\":\"The First Autism ETF Raises A Harder Question About Impact Investing\",\"datePublished\":\"2026-07-06T09:47:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/\"},\"wordCount\":2153,\"publisher\":{\"@id\":\"http:\\\/\\\/www.fundavia.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.fundavia.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/fundavia_image_20260706_040085.jpg\",\"articleSection\":[\"Equity ETFs\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/\",\"url\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/\",\"name\":\"Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes *\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.fundavia.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.fundavia.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/fundavia_image_20260706_040085.jpg\",\"datePublished\":\"2026-07-06T09:47:39+00:00\",\"description\":\"Defiance has introduced the first autism-impact ETF, ASD, blending financial innovation with social responsibility. This initiative reflects a growing trend in equity-based ETFs to align with social causes.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.fundavia.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/fundavia_image_20260706_040085.jpg\",\"contentUrl\":\"https:\\\/\\\/www.fundavia.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/fundavia_image_20260706_040085.jpg\",\"width\":1080,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.fundavia.com\\\/etfs-index-investing\\\/equity-etfs\\\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\\\/\\\/www.fundavia.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The First Autism ETF Raises A Harder Question About Impact Investing\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/www.fundavia.com\\\/#website\",\"url\":\"http:\\\/\\\/www.fundavia.com\\\/\",\"name\":\"Fundavia | Funds, ETFs & Institutional Investing\",\"description\":\"Fundavia provides deep analysis on ETFs, funds, and institutional investment strategies shaping global financial markets and capital allocation.\",\"publisher\":{\"@id\":\"http:\\\/\\\/www.fundavia.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\\\/\\\/www.fundavia.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/www.fundavia.com\\\/#organization\",\"name\":\"Fundavia | Funds, ETFs & Institutional Investing\",\"url\":\"http:\\\/\\\/www.fundavia.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"http:\\\/\\\/www.fundavia.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.fundavia.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/fundavia.png\",\"contentUrl\":\"https:\\\/\\\/www.fundavia.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/fundavia.png\",\"width\":251,\"height\":156,\"caption\":\"Fundavia | Funds, ETFs & Institutional Investing\"},\"image\":{\"@id\":\"http:\\\/\\\/www.fundavia.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/www.fundavia.com\\\/#\\\/schema\\\/person\\\/917222061ef2cf1c52b97293e690505b\",\"name\":\"Warren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/82207cc30d613dea4e5fc4ce5dad6b48bc98e8cde6e3910b0adcb2b12199eab1?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/82207cc30d613dea4e5fc4ce5dad6b48bc98e8cde6e3910b0adcb2b12199eab1?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/82207cc30d613dea4e5fc4ce5dad6b48bc98e8cde6e3910b0adcb2b12199eab1?s=96&d=blank&r=g\",\"caption\":\"Warren\"},\"url\":\"https:\\\/\\\/www.fundavia.com\\\/pt\\\/author\\\/warren\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes *","description":"Defiance has introduced the first autism-impact ETF, ASD, blending financial innovation with social responsibility. This initiative reflects a growing trend in equity-based ETFs to align with social causes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fundavia.com\/pt\/investimento-em-indices-de-etfs\/etfs-de-acoes\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/","og_locale":"pt_BR","og_type":"article","og_title":"Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes *","og_description":"Defiance has introduced the first autism-impact ETF, ASD, blending financial innovation with social responsibility. This initiative reflects a growing trend in equity-based ETFs to align with social causes.","og_url":"https:\/\/www.fundavia.com\/pt\/investimento-em-indices-de-etfs\/etfs-de-acoes\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/","og_site_name":"Fundavia | Funds, ETFs &amp; Institutional Investing","article_published_time":"2026-07-06T09:47:39+00:00","og_image":[{"width":1080,"height":720,"url":"https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085.jpg","type":"image\/jpeg"}],"author":"Warren","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Warren","Est. tempo de leitura":"11 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/#article","isPartOf":{"@id":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/"},"author":{"name":"Warren","@id":"http:\/\/www.fundavia.com\/#\/schema\/person\/917222061ef2cf1c52b97293e690505b"},"headline":"The First Autism ETF Raises A Harder Question About Impact Investing","datePublished":"2026-07-06T09:47:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/"},"wordCount":2153,"publisher":{"@id":"http:\/\/www.fundavia.com\/#organization"},"image":{"@id":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085.jpg","articleSection":["Equity ETFs"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/","url":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/","name":"Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes *","isPartOf":{"@id":"http:\/\/www.fundavia.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/#primaryimage"},"image":{"@id":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085.jpg","datePublished":"2026-07-06T09:47:39+00:00","description":"Defiance has introduced the first autism-impact ETF, ASD, blending financial innovation with social responsibility. This initiative reflects a growing trend in equity-based ETFs to align with social causes.","breadcrumb":{"@id":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/#primaryimage","url":"https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085.jpg","contentUrl":"https:\/\/www.fundavia.com\/wp-content\/uploads\/2026\/07\/fundavia_image_20260706_040085.jpg","width":1080,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.fundavia.com\/etfs-index-investing\/equity-etfs\/defiance-launches-the-first-autism-impact-etf-ticker-asd-donating-profits-to-autism-causes-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/www.fundavia.com\/"},{"@type":"ListItem","position":2,"name":"The First Autism ETF Raises A Harder Question About Impact Investing"}]},{"@type":"WebSite","@id":"http:\/\/www.fundavia.com\/#website","url":"http:\/\/www.fundavia.com\/","name":"Fundavia | Fundos, ETFs e Investimentos Institucionais","description":"A Fundavia fornece an\u00e1lises aprofundadas sobre ETFs, fundos e estrat\u00e9gias de investimento institucionais que moldam os mercados financeiros globais e a aloca\u00e7\u00e3o de capital.","publisher":{"@id":"http:\/\/www.fundavia.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/www.fundavia.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"http:\/\/www.fundavia.com\/#organization","name":"Fundavia | Fundos, ETFs e Investimentos Institucionais","url":"http:\/\/www.fundavia.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"http:\/\/www.fundavia.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.fundavia.com\/wp-content\/uploads\/2025\/12\/fundavia.png","contentUrl":"https:\/\/www.fundavia.com\/wp-content\/uploads\/2025\/12\/fundavia.png","width":251,"height":156,"caption":"Fundavia | Funds, ETFs & Institutional Investing"},"image":{"@id":"http:\/\/www.fundavia.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"http:\/\/www.fundavia.com\/#\/schema\/person\/917222061ef2cf1c52b97293e690505b","name":"Warren","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/82207cc30d613dea4e5fc4ce5dad6b48bc98e8cde6e3910b0adcb2b12199eab1?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/82207cc30d613dea4e5fc4ce5dad6b48bc98e8cde6e3910b0adcb2b12199eab1?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/82207cc30d613dea4e5fc4ce5dad6b48bc98e8cde6e3910b0adcb2b12199eab1?s=96&d=blank&r=g","caption":"Warren"},"url":"https:\/\/www.fundavia.com\/pt\/author\/warren\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fundavia.com\/pt\/wp-json\/wp\/v2\/posts\/984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fundavia.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fundavia.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fundavia.com\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fundavia.com\/pt\/wp-json\/wp\/v2\/comments?post=984"}],"version-history":[{"count":0,"href":"https:\/\/www.fundavia.com\/pt\/wp-json\/wp\/v2\/posts\/984\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fundavia.com\/pt\/wp-json\/wp\/v2\/media\/983"}],"wp:attachment":[{"href":"https:\/\/www.fundavia.com\/pt\/wp-json\/wp\/v2\/media?parent=984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fundavia.com\/pt\/wp-json\/wp\/v2\/categories?post=984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fundavia.com\/pt\/wp-json\/wp\/v2\/tags?post=984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}